Trade Summary

4 days ago, ROTHBLATT MARTINE A, serving as Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $537.05 per share, for a total transaction value of $5,101,939.44. Following this transaction, ROTHBLATT MARTINE A now holds 324,443 shares of UTHR.

This sale represents a 2.84% decrease in ROTHBLATT MARTINE A's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, July 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, July 20, 2026 at 4:32 PM ET, 3 days after the trade was made.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.